Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06LQY
|
|||
| Former ID |
DIB014755
|
|||
| Drug Name |
BI-1
|
|||
| Synonyms |
BI-1; AC1L2R2F; 145551-68-4; SCHEMBL8964991; CHEMBL209801; 1-(7-(2-Hydroxyethyl)dodecahydro-3a-methyl-1H-benz(e)inden-3-yl)ethanone; 3S-(3alpha,3aalpha,5abeta,7alpha,9aalpha,9bbeta)-1-(7-(2-Hydroxyethyl)dodecahydro-3a-methyl-1H-benz(e)inden-3-yl)ethanone; 1-[(3S,3aS,5aR,7R,9aR,9bS)-7-(2-hydroxyethyl)-3a-methyl-1,2,3,4,5,5a,6,7,8,9,9a,9b-dodecahydrocyclopenta[a]naphthalen-3-yl]ethanone; Ethanone, 1-(dodecahyro-7-(2-hydroxyethyl)-3a-methyl-1H-benz(e)inden-3-yl)-, (3S-(3alpha,3aalpha,5abeta,7alpha,9aalpha,9bbeta))-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 2 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H30O2
|
|||
| Canonical SMILES |
CC(=O)C1CCC2C1(CCC3C2CCC(C3)CCO)C
|
|||
| InChI |
1S/C18H30O2/c1-12(20)16-5-6-17-15-4-3-13(8-10-19)11-14(15)7-9-18(16,17)2/h13-17,19H,3-11H2,1-2H3/t13-,14+,15+,16+,17-,18+/m0/s1
|
|||
| InChIKey |
OOTXTVKIKCULJJ-UIGZQWRCSA-N
|
|||
| CAS Number |
CAS 145551-68-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of Morphosys. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.